Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Women with mid-trimester pregnancy seeking abortion
Having an ongoing pregnancy of 13-22 weeks gestation
Be willing to undergo surgical completion if necessary
Have no contraindications to study procedures, according to provider
Be willing and able to consent to participate in the study
Be willing to follow study procedures
Known allergy to mifepristone or misoprostol/prostaglandin
Any contraindications to vaginal delivery, including placenta previa